Avricore Health Inc.
AVCRF
$0.04
$0.0121.97%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.37M | 2.21M | 2.96M | 3.49M | 3.47M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.37M | 2.21M | 2.96M | 3.49M | 3.47M |
| Cost of Revenue | 775.90K | 1.27M | 1.71M | 2.12M | 2.15M |
| Gross Profit | 589.70K | 946.70K | 1.25M | 1.37M | 1.32M |
| SG&A Expenses | 1.17M | 1.37M | 1.30M | 1.24M | 1.19M |
| Depreciation & Amortization | 3.30K | 2.80K | 2.50K | 2.20K | 1.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.95M | 2.64M | 3.01M | 3.36M | 3.34M |
| Operating Income | -582.20K | -426.00K | -48.40K | 130.90K | 126.60K |
| Income Before Tax | -1.17M | -1.03M | -654.70K | -475.80K | 77.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.17 | -1.03 | -0.65 | -0.48 | 0.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.17M | -1.03M | -654.70K | -475.80K | 77.00K |
| EBIT | -582.20K | -426.00K | -48.40K | 130.90K | 126.60K |
| EBITDA | -413.70K | -205.20K | 223.70K | 457.10K | 465.50K |
| EPS Basic | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 405.11M | 404.22M | 402.80M | 401.25M | 399.68M |
| Average Diluted Shares Outstanding | 405.11M | 404.22M | 408.53M | 406.98M | 405.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |